Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04205409
Title Nivolumab for the Treatment of Relapsed or Refractory Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

chronic lymphocytic leukemia

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma

multiple myeloma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.